Evaluation of Returning to the Fields of Athletes in the Light of the Effects of Coronavirus on the Cardiovascular System

Öz

Coronavirus-19 (Covid-19) infection affected the whole world and became the biggest health problem in 2020. Although Covid-19 infection causes endothelial dysfunction and affects all organs, its main effects are on the heart and lungs. Although professional athletes are not shown as a risk group, many teams or athletes have been infected with the virus. Symptomatic and asymptomatic patients have emerged, especially after transmission during sports activities where social distance cannot be maintained. Today, new algorithms are needed for the return of infected athletes to the fields. The aim of this review to discuss return of the athletes to the fields after infection with considering the effects of the virus on the cardiovascular system.

Anahtar Kelimeler

• Covid-19
• athlete
• return
• field
• heart

Koronavirüsün Kardiyovasküler Sistem Üzerine Etkileri Işığında Sporcuların Yeniden Sahalara Dönüşünün Değerlendirilmesi

Öz

Tüm dünyayı etkisi altına alan ve 2020 yılının en büyük sağlık sorunu haline gelen koronavirüs-19 (Covid-19) enfeksiyonu endotel disfonksiyonuna yol açıp tüm organları etkilemesine rağmen temel etkilerini kalp ve akciğer üzerinde göstermektedir. Profesyonel sporcular risk grubu olarak gösterilmemesine rağmen birçok takım veya sporcular virüs ile enfekte olmuştur. Özellikle sosyal mesafenin korunamadığı sportif faaliyetler sırasındaki bulaş sonrasında semptomatik ve asemptomatik hastalar ortaya çıkmıştır. Günümüzde enfeksiyonu geçiren sporcuların sahalara dönüşü ile ilgili yeni algoritmalara ihtiyaç duyulmaya başlanmıştır. Bu derlemede Covid-19 hastalığı geçiren profesyonel sporcularda virüsün kardiyovasküler sistem üzerine etkilerinin göz önüne alınarak sporcularda sahalara yeniden dönüşünün nasıl olması gerektiğinin tartışılması amaçlanmıştır.

Anahtar Kelimeler

• Covid-19
• sporcu
• saha
• dönüş
• kalp

Kaynakça

1. Abou, I. (2020). The hypercoagulable state in COVID-19: İncidence, pathophysiology and management. Thrombosis Research, 194, 101-115.
2. Asimaki, A. (2011). Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol, 4, 743-752.
3. Baggish, A. (2020). Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes. Br J Sports Med, 54, 1125-1135.
4. Barrero, A.M. (2019). Game models in soccer. From theoretical conception to practical design. Retos, 36, 543-551.
5. Becker, L.B. (1993). Incidence of cardiac arrest: a neglected factor ın evaluating survival rates. Ann Emerg Med, 22, 86-91.
6. Chang, L. (2020). Coronavirus disease 2019: Coronaviruses and blood safety. Transfus Med Rev, 34, 75-80.
7. Chen, L. (2020). The ace2 expression ın human heart indicates new potential mechanism of heart injury among patients infected with SARS-COV-2. Cardiovasc Res, 116, 1097-1100.
8. Cui, S. (2020). Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost, 1-4.

9. Dermot, P. (2020). A game plan for the resumption of sport and exercise after coronavirus disease 2019 (covıd-19) infection. JAMA Cardiology. 5(10), 1085-108.
10. Feldman, A.M. (2000). Myocarditis. N Engl J Med, 343, 1388-1398.
11. Guan, W.J. (2020). China medical treatment expert group for covid-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med, 382, 1708-1720.
12. Hamming, I. (2004). Tissue distribution of ace 2 protein, the functional receptor for sars coronavirus. A first step in understanding sars pathogenesis. J. Pathol. 203, 631-637.
13. Helder, D. (2020). Return to play after COVID-19: a sport cardiologist’s view. Br J Sports Med, 54, 1125-1135.
14. Ho, J.S., Sia, C.H., Chan, M.Y., Lin, W., Wong, R.C. (2020). Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung. 49, 681-685.
15. Liu, K. (2020). Clinical characteristics of novel coronavirus cases in tertiary hospitals in hubei province. Chin Med J, 133, 1025-1031.
16. Lurz, P. (2016). Comprehensive cardiac magnetic resonance ımaging in patients with suspected myocarditis the myoracer trial. J Am Coll Cardiol, 67(15), 1800-1811.
17. Maron, B.J. (2009). Sudden deaths ın young competitive athletes: Analysis of 1866 deaths in the United States, 1980–2006. Circulation, 119, 1085-1092.
18. Mayr, A. (2017). Myocardial edema ın acute myocarditis: relationship of t2 relaxometry and late enhancement burden by using dual-contrast turbo spin-echo MRI. Int J Card Imaging, 33(11), 1789-1794.
19. McKinney, J. (2020). Covıd-19 myocarditis and return-to-play: Reflections and recommendations from a canadian working group. Canadian Journal of Cardiology. Online ahead of print.
20. Musher, D.M. (2019). Acute infection and myocardial infarction. N Engl J Med, 380, 171-176.
21. Nicholas, C. (2020). Comparison of molecular testing strategies for COVID-19 control: A mathematical modelling study. Lancet Infect Dis, 20, 1381-1389.
22. Pan, J.A. (2018). Diagnostic performance of extracellular volume, native T1, and T2 mapping versus lake louise criteria by cardiac magnetic resonance for detection of acute myocarditis. Circ Cardiovasc Imaging, 11(7), 598-600.
23. Pan, S.F. (2003). Cardiac arrest ın severe acute respiratory syndrome: analysis of 15 cases. Chinese Journal of Tuberculosis and Respiratory Diseases, 26, 602–605.
24. Peretto, G. (2019). Arrhythmias ın myocarditis: state of the art. Heart Rhythm 16, 793-801.
25. Peretto, G. (2020). Ventricular arrhythmias ın myocarditis: characterization and relationships with myocardial ınflammation. J Am Coll Cardiol, 75, 1046-1057.
26. Phelan, D. (2020). Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19. Jacc: Cardiovascular İmaging. 2635-2652.
27. Philipp, S. (2020). Return to sports after Covıd-19 infection. Eur Heart J, 41(46), 4382-4384.
28. Phillips, M.D. (2010). Resistance training at eight repetition maximum reduces the ınflammatory milieu in elderly women. Med Sci Sports Exerc, 42(2), 314-325.
29. Rajpal, S. (2020). Cardiovascular magnetic resonance findings in competitive athletes recovering from covıd-19 infection. JAMA Cardiology, Online ahead of print.
30. Robert, D. (2008). Acute viral myocarditis. European Heart Journal, 29, 2073-2082.
31. Ruan, Q. (2020). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from wuhan, china. Intensive Care Med, 46, 846-848.
32. Schellhorn, P. (2020). Return to sports after COVID-19 infection. Cardiopulse. 4382-4384.
33. Schultheiss, H.P. (2001). Myocarditis and ınflammatory cardiomyopathy. DiMarco JP, Crawford MH, eds. Cardiology. 1-12. Situation reports retriweired from Weekly epidemiological update. 22 December 2020 (who.int)
34. Toresdahl, B.G. (2019). Coronavirus Disease 2019 (COVID-19): Considerations for the Competitive Athlete. Sports Health, 221-224.
35. Wilson, M.G. (2020). Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. Br J Sports Med, 54, 1157–1161.
36. Xiong, T.Y., Redwood, S., Prendergast, B., and Chen, M. (2020). Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J, 1798-1800.
37. Xu Z. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 8, 420-422.